Clinical Trial Update: Effects of Second-generation Antihistamine Bepotastine on Cough Outcomes in Cough Patients With Allergic Rhinitis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effects of the second-generation antihistamine bepotastine on cough outcomes in patients with allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Cough

Drugs mentioned

• bepotastine (bepotastine)

Snippet

Sponsor: Asan Medical Center | Conditions: Allergic Rhinitis, Cough | Phase 4 | Status: COMPLETED